SLNO

Q: What is the price of Soleno Therapeutics (SLNO) today?

The current price of Soleno Therapeutics (SLNO) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 46.30 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Soleno Therapeutics (SLNO) pay dividends?

Soleno Therapeutics (SLNO) did not pay dividends over the past year.

Soleno Therapeutics Inc.

Price

$ -

return (12m)

0.00%

p/e

28.70

p/bv

5.56

DIVIDEND YIELD

0.00%

SLNO price

SLNO

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment SLNO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals SLNO

review the fundamentals of Soleno Therapeutics shares

P/E

28.70

Sector: -4.15 Industry: -4.15

P/S (PSR)

9.67

Sector: -4.21 Industry: -4.21

P/BV

5.56

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

15.79%

Sector: -65.91% Industry: -65.91%

ROE

19.37%

Sector: -68.17% Industry: -68.17%

ROIC

39.07%

Sector: -2,907.20% Industry: -2,907.20%

NET MARGIN

33.70%

Sector: -42.15% Industry: -42.15%

GROSS MARGIN

98.64%

Sector: 37.04% Industry: 37.04%

OPERATING MARGIN

31.40%

Sector: -41.14% Industry: -41.14%

EV/EBITDA

25.76

Sector: -4.32 Industry: -4.32

EV/EBIT

26.26

Sector: -4.38 Industry: -4.38

PRICE-TO-ASSETS

4.53

Sector: 1.38 Industry: 1.38

BVPS

9.53

Sector: 1.83 Industry: 1.83

EPS

1.85

Sector: -2.20 Industry: -2.20

EQUITY-TO-ASSETS RATIO

0.81

Sector: 0.41 Industry: 0.41

LIABILITIES / ASSETS

0.19

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Soleno Therapeutics ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SLNO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.67	6.91	25.92%	2.23%	$ 561.22 B	21.83%
PFE	19.36	1.60	8.29%	6.75%	$ 145.01 B	11.83%
ABBV	105.03	-57.74	-54.98%	3.12%	$ 381.79 B	5.79%
NVO	10.53	6.36	60.40%	4.15%	$ 199.76 B	37.15%
MRK	33.87	6.59	19.45%	2.71%	$ 302.60 B	13.59%
AZN	27.89	6.11	21.93%	1.71%	$ 289.71 B	17.19%
GILD	18.11	7.12	39.33%	2.37%	$ 166.88 B	30.99%
BMY	16.66	6.03	36.19%	4.20%	$ 121.18 B	15.01%
ZTS	12.98	10.61	81.75%	2.50%	$ 34.32 B	27.79%
REGN	15.02	2.11	14.08%	0.56%	$ 66.44 B	29.65%
HALO	23.11	36.70	158.82%	0.00%	$ 8.06 B	23.13%
AMGN	23.49	19.94	84.87%	2.85%	$ 183.22 B	20.96%
MCK	19.63	-112.06	-570.98%	0.41%	$ 93.46 B	1.18%
HRMY	12.01	1.92	16.00%	0.00%	$ 1.75 B	16.20%
VRTX	25.44	5.70	22.41%	0.00%	$ 110.37 B	35.51%
CAH	30.33	-17.65	-58.20%	1.02%	$ 47.16 B	0.62%
ADMA	11.76	4.98	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

SLNO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Soleno Therapeutics

Soleno Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

27 years

Founded: 1999

2014

Time since IPO - 12 years

31

Employees

Soleno Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1,000.00 Trillions, with shareholders equity totaling $495.80 Millions.

The company employs approximately 31 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Soleno Therapeutics Inc. reported $285.01 Millions in revenue, generating net income of $96.04 Millions.

Key financial metrics include a P/E ratio of 28.70, a price-to-book (P/B) ratio of 5.56, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SLNO.

Market cap

$ 1,000.00 Trillions

Net worth

$ 495.80 Millions

$ 495,800,000.00

Assets

$ 608.39 Millions

$ 608,390,000.00

Total Shares Outstanding

52.00 Millions

52,000,000

Average Daily Trading Volume

$ 3.87 Millions

$ 3,871,922.20

Sector

Health Care

Industry

Biotechnology

SLNO

SLNO revenue and profits

Financial Results SLNO

DRAG THE FRAME TO SEE MORE DATA

SLNO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 766.08 7,41% (12M)

P/E

19.63

0.41%

ROE

-570.98%

P/BV

-112.06

CAH - Cardinal Health

$ 200.68 32,88% (12M)

P/E

30.33

1.02%

ROE

-58.20%

P/BV

-17.65

JNJ - Johnson & Johnson

$ 234.34 58,44% (12M)

P/E

26.67

2.23%

ROE

25.92%

P/BV

6.91

MRK - Merck & Co.

$ 122.41 63,49% (12M)

P/E

33.87

2.71%

ROE

19.45%

P/BV

6.59

AZN - AstraZeneca

$ 187.03 34,10% (12M)

P/E

27.89

1.71%

ROE

21.93%

P/BV

6.11

ABBV - AbbVie

$ 215.70 21,44% (12M)

P/E

105.03

3.12%

ROE

-54.98%

P/BV

-57.74

NVO - Novo Nordisk

$ 44.96 --30,01% (12M)

P/E

10.53

4.15%

ROE

60.40%

P/BV

6.36

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 766.08 7,41% (12 M)

P/L

19.63

0.41%

ROE

-570.98%

P/VP

-112.06

CAH - Cardinal Health

$ 200.68 32,88% (12 M)

P/L

30.33

1.02%

ROE

-58.20%

P/VP

-17.65

JNJ - Johnson & Johnson

$ 234.34 58,44% (12 M)

P/L

26.67

2.23%

ROE

25.92%

P/VP

6.91

MRK - Merck & Co.

$ 122.41 63,49% (12 M)

P/L

33.87

2.71%

ROE

19.45%

P/VP

6.59

AZN - AstraZeneca

$ 187.03 34,10% (12 M)

P/L

27.89

1.71%

ROE

21.93%

P/VP

6.11

ABBV - AbbVie

$ 215.70 21,44% (12 M)

P/L

105.03

3.12%

ROE

-54.98%

P/VP

-57.74

NVO - Novo Nordisk

$ 44.96 --30,01% (12 M)

P/L

10.53

4.15%

ROE

60.40%

P/VP

6.36

Frequently Asked Questions

What is the price of Soleno Therapeutics (SLNO) today?

The current price of Soleno Therapeutics (SLNO) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 46.30 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Soleno Therapeutics (SLNO) pay dividends?

Soleno Therapeutics (SLNO) did not pay dividends over the past year.

Is Soleno Therapeutics (SLNO) a good investment?

Soleno Therapeutics (SLNO) is currently trading at $ 0.00 with a P/E ratio of 28.70. This represents a 2,021% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Soleno Therapeutics (SLNO) stock?

You can buy Soleno Therapeutics (SLNO) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol SLNO and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Soleno Therapeutics (SLNO) yield today?

Over the past month, Soleno Therapeutics (SLNO) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Soleno Therapeutics (SLNO) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SLNO

Soleno Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SLNO

review the fundamentals of Soleno Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Soleno Therapeutics

Soleno Therapeutics Inc.

United States

27 years

2014

31

PROFIT X PRICE SLNO

Financial Results SLNO

SLNO cash flow

Asset, Revenue and Profit Growth - SLNO

SLNO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions